Skip to content

Kinetics of various routine paraclinical parameters (triiodothyronine, L-thyroxine, thyroxine-binding globulin, bilirubin) during hemoadsorption with CytoSorb® with special consideration of the adsorber saturation kinetics.

Kinetics of various routine paraclinical parameters (triiodothyronine, L-thyroxine, thyroxine-binding globulin, bilirubin) during hemoadsorption with CytoSorb® with special consideration of the adsorber saturation kinetics. - CytoSoFTT34

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00025926
Enrollment
20
Registered
2021-08-04
Start date
2023-10-05
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemoadsorption R57.2

Interventions

Group 1: Intensive care patients in septic shock under hemoadsorption. Blood samples will be taken at baseline, 60, 120, 240, 480 minutes after and 60 minutes before adsorber change. Concentrations of

Sponsors

Universitätsklinik für Anästhesiologie, operative Intensivmedizin, Rettungsmedizin, Schmerztherapie Klinikum Herford AöR
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. intensive care patients with septic shock 2. indication for adjunctive hemoadsorption

Exclusion criteria

Exclusion criteria: 1. pregnant, postpartal or breast-feeding patients 2. patients with known thryroid disease 3. known pituitary disease 4. known thalamus disease

Design outcomes

Primary

MeasureTime frame
Concentration of triiodothyronine, thyroxine and thyroxine-binding globulin in the blood at the different time points during CytoSorb treatment.

Secondary

MeasureTime frame
Concentration of bilirubin in the blood at the different time points during CytoSorb treatment.

Countries

Germany

Contacts

Public ContactDietrich Henzler

Universitätsklinik für Anästhesiologie, operative Intensivmedizin, Rettungsmedizin, Schmerztherapie, Campus OWL, Klinikum Herford AöR

dietrich.henzler@klinikum-herford.de+49 (0)5221 94 2481

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026